Visit The Boston Globe Share on Twitter Share on Facebook Comment on this Scroll to top of page Laura Crimaldi Globe Staff June 19, 2018 A federal jury in Boston on Monday awarded $18.4 million in damages to a man who alleged that two of his former physicians failed to test him for HIV despite risk factors that made him more vulnerable to contracting the disease.Sean Stentiford, 48, was more susceptible to developing the virus that causes AIDS because he is gay and earlier in his life worked as a paramedic, a job that regularly exposed him to bodily fluids, his lawyer, David P. Angueira, said Tuesday.But even though he consented to an HIV test in 2007, his doctors never performed one. About three years later, another doctor recommended the test, which came back positive, Angueira said. By then, the disease progressed to AIDS, causing Stentiford brain damage and ending his career as a lawyer. Advertisement “He had a brilliant future in front of him. … [Read more...] about Federal jury awards HIV patient $18.4m in medical malpractice suit
Hiv testing boston
Grindr, a popular dating app for gay men, said it will stop sharing users' HIV data with third-party companies that analyze mobile and Web apps.The decision comes after BuzzFeed reported Monday that Grindr, used by 3.6 million daily active users worldwide, has been providing users' HIV status and their "last tested date" - information that Grindr users choose to include in their profiles - to two analytics companies. The report prompted a backlash among some users and advocacy groups that saw the sharing of data as a breach of users' trust.Bryce Case, Grindr's head of security, said that sharing information with Apptimize and Localytics is "standard industry practice for rolling out and debugging software" and was done so securely to test and optimize the app's features, such as HIV testing reminders."Any information we provide to our software vendors including HIV status information is encrypted and at no point did we share sensitive information like HIV status with advertisers," Case … [Read more...] about Grindr says it will stop sharing users’ HIV data with third-party firms amid backlash
By Jon CohenMar. 9, 2018 , 4:50 PM BOSTON—There’s no question that a simple regimen of a single daily pill can slash HIV infections in people at risk. But although millions of people around the world could benefit, only 200,000 are prescribed what’s called pre-exposure prophylaxis, or PrEP, and 75% of them are in the United States. The disparity was the focus of anguished discussions this week at the largest annual U.S. HIV/AIDS conference. “I’m frustrated,” says Linda-Gail Bekker, a researcher at the University of Cape Town in South Africa. “We have nearly 1700 infections every week in young women and girls, and this might be a way to throttle this.” PrEP, which uses antiretroviral (ARV) pills made for treatment as preventives, faces multiple obstacles, as Bekker and other discussed at the Conference on Retroviruses and Opportunistic Infections here. Many countries already struggle to provide ARVs to people who are infected and say they … [Read more...] about A daily pill can prevent HIV infections. Why don’t more people use it?
By Jon CohenMar. 9, 2018 , 11:50 AM BOSTON—Despite enormous efforts over more than 30 years, HIV/AIDS researchers have yet to develop either a vaccine or cure for the disease. But they have made progress in monkey experiments, and two studies reported here this week at the largest annual U.S. HIV/AIDS conference created serious buzz. Several AIDS vaccines have had some success in monkey models, which typically use SIV, a simian cousin of HIV that causes AIDS in rhesus macaques. But one vaccine has long stood out from the pack. Designed by Louis Picker and colleagues at Oregon Health & Science University’s Vaccine and Gene Therapy Institute in Beaverton, the vaccine stitches SIV genes into a harmless Trojan horse, cytomegalovirus. Picker’s team has given the vaccine to more than 200 monkeys and then “challenged” them with injections of a particularly nasty strain of SIV. All told, 55% of the animals became temporarily infected and then … [Read more...] about Monkeys reveal new clues toward elusive HIV vaccine and cure
By Elisabeth PainMar. 21, 2016 , 1:15 PM Adam Ruben’s tongue-in-cheek column about the common difficulties and frustrations of reading a scientific paper broadly resonated among Science Careers readers. Many of you have come to us asking for more (and more serious) advice on how to make sense of the scientific literature, so we’ve asked a dozen scientists at different career stages and in a broad range of fields to tell us how they do it. Although it is clear that reading scientific papers becomes easier with experience, the stumbling blocks are real, and it is up to each scientist to identify and apply the techniques that work best for them. The responses have been edited for clarity and brevity. How do you approach reading a paper? I start by reading the abstract. Then, I skim the introduction and flip through the article to look at the figures. I try to identify the most prominent one or two figures, and I really make sure I understand what's going … [Read more...] about How to (seriously) read a scientific paper